Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Feb;6(2):161-171.
doi: 10.1016/j.oret.2021.05.004. Epub 2021 May 12.

Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry

Affiliations
Multicenter Study

Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry

Yangjiani Li et al. Ophthalmol Retina. 2022 Feb.

Abstract

Purpose: Retinal vascular occlusion is a leading cause of profound irreversible visual loss, but the understanding of the disease is insufficient. We systematically investigated the age, gender, and laterality at the onset of retinal artery occlusion (RAO) and retinal vein occlusion (RVO) in the Intelligent Research in Sight (IRIS®) Registry.

Design: Retrospective registry cohort.

Participants: Patients with retinal vascular occlusion participating in the IRIS® Registry.

Methods: Patients who received a diagnosis of retinal vascular occlusion between 2013 and 2017 were included. Those with unspecified gender or laterality were excluded when conducting the relevant analyses. Patients were categorized into RAO, with subtypes transient retinal artery occlusion (TRAO), partial retinal artery occlusion (PRAO), branch retinal artery occlusion (BRAO), and central retinal artery occlusion (CRAO), and into RVO, with subtypes venous engorgement (VE), branch retinal vein occlusion (BRVO), and central retinal vein occlusion (CRVO). Age was evaluated as a categorical variable (5-year increments). We investigated the association of age, gender, and laterality with the onset frequency of retinal vascular occlusion subtypes.

Main outcome measures: The frequency of onset of RAO and RVO subtypes by age, gender and laterality.

Results: A total of 1 251 476 patients with retinal vascular occlusion were included, 23.8% of whom had RAO, whereas 76.2% had RVO. Of these, 1 248 656 and 798 089 patients were selected for analyses relevant to gender and laterality, respectively. The onset frequency of all subtypes increased with age. PRAO, BRAO, CRAO, and CRVO presented more frequently in men (53.5%, 51.3%, 52.6%, and 50.4%, respectively), whereas TRAO, VE, and BRVO presented more frequently in women (54.9%, 56.0%, and 54.5% respectively). All RAO subtypes and BRVO showed a right-eye onset preference (TRAO, 51.7%; PRAO, 54.4%; BRAO, 53.5%; CRAO, 53.4%; and BRVO, 51.0%), whereas VE and CRVO exhibited a left-eye onset preference (53.3% and 50.9%, respectively).

Conclusions: Although retinal vascular occlusion incidence increases with age regardless of subtypes, we found various subtype-specific disease-onset differences related to gender and, in particular, ocular laterality. These findings may improve understanding of the specific cause of retinal vascular occlusions of different subtypes and their relationships with structural and anatomic asymmetries of the vascular system.

Keywords: Big data; Demographics; Epidemiology; Retinal artery occlusion; Retinal vein occlusion.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Selection of cases for analysis.
The number of cases retrieved from the entire Intelligent Research in Sight (IRIS) Registry database and included for analyses. The percentages of excluded cases were based on the 1,289,836 cases diagnosed with retinal vascular occlusion.
Figure 2.
Figure 2.. Distribution of the number of included cases by age, gender, and laterality at onset.
Distribution of numbers of cases by age, gender and laterality at first diagnosis. The numbers of men, women, and unspecified gender cases are presented inline in each age category. Each bar shows the cumulative case numbers of right, left, both, and unspecified eye at onset. A. The entire set of Intelligent Research in Sight (IRIS) Registry diagnoses (y-axis 200 times larger than other plots). B. Diagnoses of retinal vascular occlusions. C. Diagnoses of retinal artery occlusions. D. Diagnoses of retinal vein occlusions.
Figure 3.
Figure 3.. Distribution of the number of included cases of retinal artery occlusion by subtype, age, gender, and laterality at onset.
Distribution of numbers of cases by age and gender at first diagnosis. The numbers of men, women, and unspecified gender cases are presented inline in each age category. Each bar shows the cumulative case number of right, left, both, and unspecified eye at onset. A. Transient retinal artery occlusion. B. Partial retinal artery occlusion. C. Branch retinal artery occlusion. D. Central retinal artery occlusion.
Figure 4.
Figure 4.. Distribution of the number of included cases of retinal vein occlusion by subtype, age, gender, and laterality at onset.
Distribution of numbers of cases by age and gender at first diagnosis. The numbers of men, women, and unspecified gender cases are presented inline in each age category. Each bar shows the cumulative case number of right, left, both, and unspecified eye at onset. A. Venous engorgement. B. Branch retinal vein occlusion. C. Central retinal vein occlusion.

Similar articles

Cited by

References

    1. Hayreh SS. Ocular vascular occlusive disorders: Natural history of visual outcome. Prog Retin Eye Res. 2014;41:1–25 - PMC - PubMed
    1. Mlaco A, Mlaco N, Bejtovic D, Dzubur A, Spuzic M. Venous Thromboembolism During Ten-year Follow up on Clinical Center University of Sarajevo. Materia Socio Medica. 2019;31(2):84. - PMC - PubMed
    1. Pershing S, Lum F, Hsu S et al. Endophthalmitis after Cataract Surgery in the United States. Ophthalmology. 2019; - PubMed
    1. Atchison EA, Wood KM, Mattox CG et al. The Real-World Effect of Intravitreous Anti–Vascular Endothelial Growth Factor Drugs on Intraocular Pressure. Ophthalmology. 2018;125(5):676–682 - PubMed
    1. Chiang MF, Sommer A, Rich WL, Lum F, Parke DW. The 2016 American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Database. Ophthalmology. 2018;125(8):1143–1148 - PubMed

Publication types

MeSH terms

LinkOut - more resources